News
Gilead Sciences’ sponsorship of a conference Wi-Fi network has landed it in hot water. | Gilead Sciences’ sponsorship of a ...
Four episodes into the final season of The Handmaid's Tale, June's (Elisabeth Moss) quest to destroy Gilead is back in full ...
Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...
The Handmaid’s Tale Season 6 finale is just a few weeks away, but fans hoping for a neatly wrapped story to June Osbourne and ...
Ipsen and its fellow French partner Genfit are competing with Intercept and Advanz’s Ocaliva, which was approved in 2016 and ...
The resistance against Gilead carries on. Here's what you need to remember before "The Handmaid's Tale" Season 6 starts.
4d
Dexerto on MSNWhat is a Martha? The Handmaid’s Tale social rankings explainedWith The Handmaid’s Tale Season 6 airing now, here’s what you need to know about Marthas and the social hierarchy for women ...
As the final season of "The Handmaid's Tale" begins today, we're taking a look back on everything to know about the hit Hulu ...
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...
It didn't take long for June to plan a return to Gilead — with Luke by her side — while Serena is getting courted by newcomer ...
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
14h
Screen Rant on MSNThe Testaments Is Now The Biggest Problem With The Handmaid's Tale Season 6The Handmaid's Tale is nearing its end, and since a sequel series has been confirmed, The Testaments is taking the wind out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results